Abstract 4363517: Higher visit-to-visit glucose and HbA1c variability are associated with lower gray matter and higher white matter hyperintensity volumes in older adults: The Multi-Ethnic Study of Atherosclerosis (MESA)
Background: Dysglycemia is a well-established risk factor for cognitive decline. The association of long-term glucose control with early neuroimaging markers of dementia remains largely unexplored. Hypothesis: Higher visit-to-visit variability in glucose and HbA1c, indicating worse glucose control, are associated with lower total and regional gray matter volume (GMV) and higher white matter hyperintensity (WMH) volume. Methods: Fasting glucose (FG) was measured in MESA participants at Exam 1 (2000–02) and each of 5 follow-up exams through Exam 6 (2016-18), and HbA1c was measured at Exam 2 (2002–04), Exam 5 (2010–12), and Exam 6. We calculated intraindividual variability in FG and HbA1c as the SD (SD FG ; SD A1c ), average real variability (ARV FG ; ARV A1c ), and variability independent of the mean (VIM FG ; VIM A1c ) through Exam 6. Total and regional GMV and WMH volume were assessed by 3T brain MRI (2017-22). We report the SD difference in GMV and log-unit difference in WMH volume per two-fold increment in glucose or HbA1c variability with 95% CI from multivariable linear regression models adjusted for total intracranial volume, study site, age, sex, race/ethnicity, education, vascular risk factors, and APOE ε4 allele status. Results: A total of 1,424 Exam 6 participants (mean (SD) age 72 (8) yrs; 46% men; 28% with diabetes at Exam 6) had ≥3 FG measurements (mean: 5.9 measurements) and MRI data. Two-fold increments of SD FG , ARV FG , and VIM FG were associated with –0.08 (–0.11, –0.06), –0.09 (–0.12, –0.06), and –0.10 (–0.14, –0.06) SD differences in total GMV and 0.13 (0.06, 0.19), 0.13 (0.06, 0.20), and 0.16 (0.05, 0.26) log-unit differences in WMH volumes, respectively (Table 1). Associations appeared strongest with frontal lobe GMV. Further adjustment for mean FG through Exam 6 only modestly attenuated results. In 839 participants with 3 HbA1c measurements, two-fold increments of SD A1c , ARV A1c , and VIM A1c were associated with –0.20 (–0.30, –0.10), –0.77 (–1.20, –0.38), and –0.26 (–0.39, –0.12) SD differences in total GMV and 0.3 (0.04, 0.55), 1.40 (0.38, 2.3), and 0.36 (0.02, 0.70) log-unit differences in WMH volumes, respectively (Table 2). Neither glucose nor HbA1c variability were associated with temporal lobe or hippocampal volumes. Associations did not differ by diabetes status. Conclusion: Higher variability of glucose and HbA1c over 16–18 years were associated with lower GMV and higher WMH volumes in a diverse, community dwelling sample of older adults.
Authors
- Ivan Krizan
- Susan R. Heckbert (ORCID: https://orcid.org/0000-0002-7100-512X)
- Ilya M. Nasrallah (ORCID: https://orcid.org/0000-0003-2346-7562)
- Morgana Mongraw‐Chaffin (ORCID: https://orcid.org/0000-0001-6541-7198)
- José A. Luchsinger (ORCID: https://orcid.org/0000-0002-5886-3648)
- Elili Brown
- Kathleen M. Hayden (ORCID: https://orcid.org/0000-0002-7745-3513)
- Jordan E. Tanley (ORCID: https://orcid.org/0009-0006-0525-9662)
- Timothy M. Hughes (ORCID: https://orcid.org/0000-0002-2919-7199)
- Nick Bryan
- Christopher L. Schaich (ORCID: https://orcid.org/0000-0002-5302-0828)
- Michael P. Bancks (ORCID: https://orcid.org/0000-0003-3694-6060)
Institutions
- University of Washington (US)
- Wake Forest University (US)
- Columbia University (US)
- University of Pennsylvania (US)
- MedStar Health (US)
Publication Details
- Journal
- Circulation
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1161/circ.152.suppl_3.4363517
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00